Compare stocks

Drägerwerk AG & Co. KGaA is a German company specializing in medical and safety technology. The company provides a range of products and solutions in the fields of critical care, which includes anesthesia workstations, ventilators, and patient monitoring, as well as safety products for personal protection, gas detection, and firefighting. Dräger was founded in 1889 and is headquartered in Lübeck, Germany. Its operations extend globally, serving various industries such as healthcare, emergency services, mining, and industrial applications. Drägerwerk's strategic strength lies in its focus on high-quality, technologically advanced products and its long-standing expertise in medical and safety technologies.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.